Patents Assigned to Pulsar Vascular, Inc.
  • Patent number: 11633189
    Abstract: Implantable therapeutic devices and methods for endovascular placement of devices at a target site, such an opening at a neck of an aneurysm, are disclosed. Selected embodiments of the present technology have closures that at least partially occlude the neck of an aneurysm to stabilize embolic or coagulative treatment of the aneurysm.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: April 25, 2023
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Gilbert Clarke, Brent Gerberding, Robert M. Abrams, Masoud Molaei
  • Publication number: 20220387042
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Application
    Filed: August 17, 2022
    Publication date: December 8, 2022
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
  • Patent number: 11457923
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: October 4, 2022
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
  • Publication number: 20220280164
    Abstract: The present technology relates to aneurysm devices with additional anchoring mechanisms, and associated systems and methods. The aneurysm device is endovascularly deliverable to a site proximate an aneurysm near a parent artery with bifurcating branches. The device can include a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm. The closure structure can be formed from a generally flat pattern and is transformable between a compressed configuration and a deployed configuration. The device can also have one or more lodging elements which fold to form loop elements configured for anchoring within at least one of the bifurcating branches. The struts of the lodging elements can include hinge points which bias the folding of the lodging elements. The devices further include a supplemental stabilizer connected to the closure structure and configured to reside in the parent artery.
    Type: Application
    Filed: May 27, 2022
    Publication date: September 8, 2022
    Applicant: PULSAR VASCULAR, INC.
    Inventor: Brent GERBERDING
  • Patent number: 11344311
    Abstract: The present technology relates to aneurysm devices with additional anchoring mechanisms, and associated systems and methods. The aneurysm device is endovascularly deliverable to a site proximate an aneurysm near a parent artery with bifurcating branches. The device can include a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm. The closure structure can be formed from a generally flat pattern and is transformable between a compressed configuration and a deployed configuration. The device can also have one or more lodging elements which fold to form loop elements configured for anchoring within at least one of the bifurcating branches. The struts of the lodging elements can include hinge points which bias the folding of the lodging elements. The devices further include a supplemental stabilizer connected to the closure structure and configured to reside in the parent artery.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: May 31, 2022
    Assignee: PULSAR VASCULAR, INC.
    Inventor: Brent Gerberding
  • Publication number: 20220079601
    Abstract: Implantable devices for placement at a cavity or opening such as an aneurysm are disclosed. The implantable devices, in a deployed condition, have a generally inverted U-shaped profile with a curved or angled framework support structure sized and configured for placement in proximity to tissue surrounding the opening and anchoring legs extending proximally from the framework structure sized and configured to contact the wall of a neighboring lumen at opposed locations. Occlusive and semi-occlusive membranes may be associated with the framework support structure and deployed over the opening to provide exclusion of the opening and flow diversion. Proximal anchoring segments providing additional lumen wall surface area contact for the implantable device following deployment may be incorporated.
    Type: Application
    Filed: November 29, 2021
    Publication date: March 17, 2022
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Brent GERBERDING, Robert M. ABRAMS, Gilbert CLARKE
  • Patent number: 11185333
    Abstract: Implantable devices for placement at a cavity or opening such as an aneurysm are disclosed. The implantable devices, in a deployed condition, have a generally inverted U-shaped profile with a curved or angled framework support structure sized and configured for placement in proximity to tissue surrounding the opening and anchoring legs extending proximally from the framework structure sized and configured to contact the wall of a neighboring lumen at opposed locations. Occlusive and semi-occlusive membranes may be associated with the framework support structure and deployed over the opening to provide exclusion of the opening and flow diversion. Proximal anchoring segments providing additional lumen wall surface area contact for the implantable device following deployment may be incorporated.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: November 30, 2021
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Brent Gerberding, Robert M. Abrams, Gilbert Clarke
  • Publication number: 20200214713
    Abstract: The present technology relates to aneurysm devices with additional anchoring mechanisms, and associated systems and methods. The aneurysm device is endovascularly deliverable to a site proximate an aneurysm near a parent artery with bifurcating branches. The device can include a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm. The closure structure can be formed from a generally flat pattern and is transformable between a compressed configuration and a deployed configuration. The device can also have one or more lodging elements which fold to form loop elements configured for anchoring within at least one of the bifurcating branches. The struts of the lodging elements can include hinge points which bias the folding of the lodging elements. The devices further include a supplemental stabilizer connected to the closure structure and configured to reside in the parent artery.
    Type: Application
    Filed: March 23, 2020
    Publication date: July 9, 2020
    Applicant: PULSAR VASCULAR, INC.
    Inventor: Brent GERBERDING
  • Patent number: 10624647
    Abstract: The present technology relates to aneurysm devices with additional anchoring mechanisms, and associated systems and methods. In some embodiments, the aneurysm devices are endovascularly deliverable to a site proximate an aneurysm near a parent artery with bifurcating branches. The aneurysm devices can include a closure structure (102) comprising a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of the bifurcating branches. The devices further include a supplemental stabilizer (103) connected to the closure structure. The supplemental stabilizer is configured to reside in the parent artery. The closure structure includes a hinge point (175) where the closure structure folds to form a loop element configured for anchoring within at least one of the bifurcating branches.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: April 21, 2020
    Assignee: Pulsar Vascular, Inc.
    Inventor: Brent Gerberding
  • Publication number: 20200046361
    Abstract: An implantable closure structure is delivered using minimally invasive techniques and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Application
    Filed: October 16, 2019
    Publication date: February 13, 2020
    Applicant: Pulsar Vascular, Inc.
    Inventors: Joseph ESKRIDGE, Gilbert CLARKE, Matthew PEASE, Gregory Marlin MAST, John Conrad MUSKIVITCH
  • Patent number: 10499927
    Abstract: An implantable closure structure is delivered using minimally invasive techniques, and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: December 10, 2019
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Joseph Eskridge, Gilbert Clarke, Matthew Pease, Gregory Martin Mast, John Conrad Muskivitch
  • Publication number: 20190365386
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device comprises a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Application
    Filed: August 19, 2019
    Publication date: December 5, 2019
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
  • Publication number: 20190336134
    Abstract: Implantable therapeutic devices and methods for endovascular placement of devices at a target site, such an opening at a neck of an aneurysm, are disclosed. Selected embodiments of the present technology have closures that at least partially occlude the neck of an aneurysm to stabilize embolic or coagulative treatment of the aneurysm.
    Type: Application
    Filed: July 1, 2019
    Publication date: November 7, 2019
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Gilbert Clarke, Brent Gerberding, Robert M. Abrams, Masoud Molaei
  • Patent number: 10426487
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: October 1, 2019
    Assignee: Pulsar Vascular, Inc.
    Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
  • Publication number: 20190223880
    Abstract: Implantable devices for placement at a cavity or opening such as an aneurysm are disclosed. The implantable devices, in a deployed condition, have a generally inverted U-shaped profile with a curved or angled framework support structure sized and configured for placement in proximity to tissue surrounding the opening and anchoring legs extending proximally from the framework structure sized and configured to contact the wall of a neighboring lumen at opposed locations. Occlusive and semi-occlusive membranes may be associated with the framework support structure and deployed over the opening to provide exclusion of the opening and flow diversion. Proximal anchoring segments providing additional lumen wall surface area contact for the implantable device following deployment may be incorporated.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 25, 2019
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Brent GERBERDING, Robert M. ABRAMS, Gilbert CLARKE
  • Patent number: 10335153
    Abstract: Implantable therapeutic devices and methods for endovascular placement of devices at a target site, such an opening at a neck of an aneurysm, are disclosed. Selected embodiments of the present technology have closures that at least partially occlude the neck of an aneurysm to stabilize embolic or coagulative treatment of the aneurysm. In one embodiment, for example, an aneurysm closure device comprises a closure structure and a supplemental stabilizer. The closure structure can have a curved portion configured to extend along a first vessel, such as a side branch of a bifurcated vessel that extends along a lateral axis. The supplemental stabilizer extends from the closure structure along a longitudinal axis transverse to the lateral axis of the first vessel. The supplemental stabilizer is configured to exert an outward force against a second vessel, such as a parent vessel, that extends transversely to the first vessel.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: July 2, 2019
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Gilbert Clarke, Brent Gerberding, Robert M. Abrams, Masoud Molaei
  • Patent number: 10285709
    Abstract: Implantable devices for placement at a cavity or opening such as an aneurysm are disclosed. The implantable devices, in a deployed condition, have a generally inverted U-shaped profile with a curved or angled framework support structure sized and configured for placement in proximity to tissue surrounding the opening and anchoring legs extending proximally from the framework structure sized and configured to contact the wall of a neighboring lumen at opposed locations. Occlusive and semi-occlusive membranes may be associated with the framework support structure and deployed over the opening to provide exclusion of the opening and flow diversion. Proximal anchoring segments providing additional lumen wall surface area contact for the implantable device following deployment may be incorporated.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: May 14, 2019
    Assignee: Pulsar Vascular, Inc.
    Inventors: Brent Gerberding, Robert M. Abrams, Gilbert Clarke
  • Patent number: 10004510
    Abstract: The present technology relates to systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices. In some embodiments, the systems include a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm and a supplemental stabilizer connected to the closure structure. The supplemental stabilizer can be configured to reside in a parent artery and press outward against a luminal wall thereof. The systems can further include a shock absorbing structure coupled to a proximal end portion of the closure structure and to a distal end portion of the supplemental stabilizer. The shock absorbing structure can inhibit movement or dislodgement of the closure structure or the supplemental stabilizer relative to the aneurysm.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: June 26, 2018
    Assignee: PULSAR VASCULAR, INC.
    Inventor: Brent Gerberding
  • Publication number: 20170224353
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Application
    Filed: April 25, 2017
    Publication date: August 10, 2017
    Applicant: Pulsar Vascular, Inc.
    Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
  • Patent number: 9636117
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: May 2, 2017
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams